3-(Pyrrolidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a chemical compound characterized by its unique structure, which includes a pyridine ring substituted with a pyrrolidine moiety and a boron-containing dioxaborolane group. The presence of the pyrrolidine ring suggests potential for interactions with biological systems, possibly influencing its pharmacological properties. The dioxaborolane group is notable for its ability to form stable complexes with various nucleophiles, which can be advantageous in synthetic chemistry and drug development. This compound may exhibit solubility in organic solvents, and its reactivity can be influenced by the electron-withdrawing nature of the pyridine ring and the electron-donating properties of the pyrrolidine. Additionally, the presence of bulky tetramethyl groups in the dioxaborolane can affect steric hindrance and influence the compound's reactivity and stability. Overall, this compound's structural features suggest potential applications in medicinal chemistry and materials science, particularly in the development of boron-containing compounds.

3-(pyrrolidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

1201644-49-6: 3-(Pyrrolidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a chemical compound characterized by its unique structure, which includes a pyridine ring substituted with a pyrrolidine moiety and a boron-containing dioxaborolane group. The presence of the pyrrolidine ring suggests potential for interactions with biological systems, possibly influencing its pharmacological properties. The dioxaborolane group is notable for its ability to form stable complexes with various nucleophiles, which can be advantageous in synthetic chemistry and drug development. This compound may exhibit solubility in organic solvents, and its reactivity can be influenced by the electron-withdrawing nature of the pyridine ring and the electron-donating properties of the pyrrolidine. Additionally, the presence of bulky tetramethyl groups in the dioxaborolane can affect steric hindrance and influence the compound's reactivity and stability. Overall, this compound's structural features suggest potential applications in medicinal chemistry and materials science, particularly in the development of boron-containing compounds.

CAS 1201644-49-6

3-(pyrrolidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

3-(Pyrrolidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Ref: IN-DA000QFH